Radiotherapy and Oncology Radiotherapy and Oncology 172(2022), 32-41 Radiotherapy and Oncology, 172, 32-41. Elsevier Ireland Ltd Radiotherapy and Oncology, 172, 32-41. ELSEVIER IRELAND LTD Hoffmann, Lone; Mortensen, Hanna; Shamshad, Muhammad; Berbee, Maaike; Bizzocchi, Nicola; Bütof, Rebecca; Canters, Richard; Defraene, Gilles; Ehmsen, Mai Lykkegaard; Fiorini, Francesca; Haustermans, Karin; Hulley, Ryan; Korevaar, Erik W; Clarke, Matthew; Makocki, Sebastian; Muijs, Christina T; Murray, Luke; Nicholas, Owen; Nordsmark, Marianne; Radhakrishna, Ganesh; ... (2022). Treatment planning comparison in the PROTECT-trial randomising proton versus photon beam therapy in oesophageal cancer: Results from eight European centres. Radiotherapy and oncology, 172, pp. 32-41. Elsevier 10.1016/j.radonc.2022.04.029 Hoffmann, L, Mortensen, H, Shamshad, M, Berbee, M, Bizzocchi, N, Bütof, R, Canters, R, Defraene, G, Ehmsen, M L, Fiorini, F, Haustermans, K, Hulley, R, Korevaar, E W, Clarke, M, Makocki, S, Muijs, C T, Murray, L, Nicholas, O, Nordsmark, M, Radhakrishna, G, Thomas, M, Troost, E G C, Vilches-Freixas, G, Visser, S, Weber, D C & Møller, D S 2022, ' Treatment planning comparison in the PROTECT-trial randomising proton versus photon beam therapy in oesophageal cancer : Results from eight European centres ', Radiotherapy and Oncology, vol. 172, pp. 32-41 . https://doi.org/10.1016/j.radonc.2022.04.029